US · Healthcare

NewcelX Ltd. (NCEL)

Biotechnology

NewcelX Ltd. (NCEL) is listed on US in the Healthcare sector. Industry: Biotechnology. As of 2026-03-24, reported P/E ratio is 18.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.

Download on the App Store Get it on Google Play

Key metrics for NCEL

P/E ratio

18.00

NewcelX Ltd. (NCEL) — FAQ

What is NCEL's P/E ratio?

The price-to-earnings (P/E) ratio for NewcelX Ltd. (NCEL) is 18.00 (data as of 2026-03-24).

Does NewcelX Ltd. pay a dividend?

Dividend yield is not available in the current snapshot for NewcelX Ltd. (NCEL). Check the MyAverix Finance app for the latest dividend data.

What sector is NewcelX Ltd. in?

NewcelX Ltd. (NCEL) is classified in the Healthcare sector (Biotechnology industry).

What exchange is NCEL listed on?

NCEL is listed on US.

Full report in the app

Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.

Related Healthcare companies

Abbott Laboratories (ABT) AbbVie Inc. CDR (ABBV) Agilent Technologies Inc. (A1GI34) Aimed Bio (0009K0) Alnylam Pharmaceuticals, Inc. (A1LN34) Alvotech (ALVO) Amgen Inc (AMGN34) argenx SE (A1RG34)